Graphene in therapeutics delivery: Problems, solutions and future opportunitiesN-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteinsDevelopment of micro-fibrous solid dispersions of poorly water-soluble drugs in sucrose using temperature-controlled centrifugal spinningStructural meta-analysis of regular human insulin in pharmaceutical formulationsElastic sealants for surgical applicationsA novel technique for imaging film coating defects in the film-core interface and surface of coated tabletsIn vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion methodPhysicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion methodEffect of drug type on the degradation rate of PLGA matricesCompaction of lactose drug mixtures: quantification of the extent of incompatibility by FT-Raman spectroscopySynthesis and characterization of cyclic acetal based degradable hydrogelsOral osmotically driven systems: 30 years of development and clinical useIncreasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silicaA comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implicationsCharacterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayersPassive skin penetration enhancement and its quantification in vitroCharacterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs.Poly (methyl vinyl ether-co-maleic acid) - Pectin Based Hydrogel-Forming Systems: Gel, Film, and Microneedles.Fast therapeutic DNA internalization - A high potential transfection system based on a peptide mimicking cationic lipid.Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).PLGA nanoparticles for peroral delivery: How important is pancreatic digestion and can we control it?Tris(2-aminoethyl)amine-based α-branched fatty acid amides - Synthesis of lipids and comparative study of transfection efficiency of their lipid formulations.Investigation of the stabilizer elimination during the washing step of charged PLGA microparticles utilizing a novel HPLC-UV-ELSD method.Physiological relevant in vitro evaluation of polymer coats for gastroretentive floating tablets.Controlled penetration of ceramides into and across the stratum corneum using various types of microemulsions and formulation associated toxicity studies.SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation--part II: diffusion and permeation of model drugs.Polyglycerol fatty acid ester surfactant-based microemulsions for targeted delivery of ceramide AP into the stratum corneum: formulation, characterisation, in vitro release and penetration investigation.Characterization of lipid model membranes designed for studying impact of ceramide species on drug diffusion and penetration.Dermal targeting using colloidal carrier systems with linoleic acid.Sucrose ester nanodispersions: microviscosity and viscoelastic properties.Hydrophilic silica aerogels as dermal drug delivery systems--dithranol as a model drug.The examination of skin lipid model systems stressed by ultraviolet irradiation in the presence of transition metal ions.The automatic micrometer screw.Second-generation biopharmaceuticals.Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates.Integrity and stability studies of precipitated rhBMP-2 microparticles with a focus on ATR-FTIR measurements.Trehalose and hyaluronic acid coordinately stabilized freeze-dried pancreatic kininogenase.Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.High throughput screening of protein formulation stability: practical considerations.
P1433
Q26750485-D17EA615-CE78-4C13-9652-21104CE1A93CQ26771611-5C5321A4-DE16-438B-A87A-35E0BDE667F5Q27311607-EBA5DAAA-2CB9-4567-A1C0-2BBCDE9ED41FQ27684652-90CCF431-4106-4B62-934A-F9D00A5ECACCQ28083242-2DCF5925-773A-452B-A340-5BD0C6214C99Q28165975-9AAAB63C-778A-40EF-B43B-EC05CA82D353Q28167751-D1FEFAC7-72AF-49BE-B84F-830E86024FEAQ28196134-5810AA7D-A867-45BE-AE5E-F6B9C475E5EEQ28200407-AFE91F99-D249-432D-B494-CCABA3922C33Q28221247-0439FF06-B988-4646-A555-A667327D77EEQ28222028-740319B5-9845-4541-B5EC-9F7C507AC4FCQ28251974-58311D1C-046A-45AC-A3FB-3F97C44F5877Q28263078-565E9505-429C-4A96-BE90-04B3D17795A1Q28307966-7A29CE53-AC5A-4298-A801-2F530E423C98Q28397450-B4F3B162-D888-42DC-A213-6BDFD874049EQ29011757-120A2F2E-F6FE-4397-A2E4-5411042C4941Q29863344-2A451E7D-0895-457C-8F45-BDDB2A975122Q30235117-C7AF2C7B-A60F-4D03-BA03-E7200A597B42Q30313228-BFA5F3A5-D605-4C41-8FAA-9ECEC46BA56DQ30313595-41F347F5-458A-485F-A7C2-7DD3E8426973Q30313783-467ACD60-9777-4541-9CA5-76FF4C2C598DQ30313920-BEEC6C87-C34C-4649-8DF1-8A142F13A9CEQ30316219-80A2EB96-2A98-4CCB-92D1-DD53EBD3D0A5Q30316407-164FE0BA-C6AC-4214-AF4E-663CDFA93C03Q30317170-77A2181A-CADA-4BBF-B4E7-5F3F9F183060Q30317762-884985ED-A4A8-4E5B-BF08-313791913E8DQ30318040-9345DBEA-DFC8-42B7-982E-94B047D46567Q30318073-00FB8E64-00E6-453A-B0B0-A2A32587CC61Q30318147-B89A0D8B-D754-4E0B-BF47-94455E4BA783Q30318768-6983E43E-0D24-498B-91B8-D27EC6A63433Q30319508-B97DB67B-8705-4767-9B18-043B4B8C8C45Q30319621-B38CF549-083A-451A-8812-28FEED6BA70BQ30320972-A675BDBA-B856-4C3C-8C84-6CD3032024B8Q30321141-1559D70B-7DD0-4DB4-963B-A1D57417A275Q30342525-8B72A9E9-6B60-4D71-9EC9-07996B271F04Q30351607-81153C0F-FB48-4D74-8CD8-1A61109F89AEQ30354212-4717B3EC-E5E3-40E3-97EC-E08D6A303B98Q30356617-35F89522-794C-4739-B876-B447A338C2E2Q30357355-A7C83857-5262-4778-84A8-E5C7EA77B278Q30358051-A0D65A24-DFD5-4FBC-8558-383E03160BAE
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Elsevier
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
European Journal of Pharmaceutics and Biopharmaceutics
@ast
European Journal of Pharmaceutics and Biopharmaceutics
@da
European Journal of Pharmaceutics and Biopharmaceutics
@de
European Journal of Pharmaceutics and Biopharmaceutics
@en
European Journal of Pharmaceutics and Biopharmaceutics
@es
European Journal of Pharmaceutics and Biopharmaceutics
@fi
European Journal of Pharmaceutics and Biopharmaceutics
@fr
European Journal of Pharmaceutics and Biopharmaceutics
@it
European Journal of Pharmaceutics and Biopharmaceutics
@nb
European Journal of Pharmaceutics and Biopharmaceutics
@nl
type
label
European Journal of Pharmaceutics and Biopharmaceutics
@ast
European Journal of Pharmaceutics and Biopharmaceutics
@da
European Journal of Pharmaceutics and Biopharmaceutics
@de
European Journal of Pharmaceutics and Biopharmaceutics
@en
European Journal of Pharmaceutics and Biopharmaceutics
@es
European Journal of Pharmaceutics and Biopharmaceutics
@fi
European Journal of Pharmaceutics and Biopharmaceutics
@fr
European Journal of Pharmaceutics and Biopharmaceutics
@it
European Journal of Pharmaceutics and Biopharmaceutics
@nb
European Journal of Pharmaceutics and Biopharmaceutics
@nl
prefLabel
European Journal of Pharmaceutics and Biopharmaceutics
@ast
European Journal of Pharmaceutics and Biopharmaceutics
@da
European Journal of Pharmaceutics and Biopharmaceutics
@de
European Journal of Pharmaceutics and Biopharmaceutics
@en
European Journal of Pharmaceutics and Biopharmaceutics
@es
European Journal of Pharmaceutics and Biopharmaceutics
@fi
European Journal of Pharmaceutics and Biopharmaceutics
@fr
European Journal of Pharmaceutics and Biopharmaceutics
@it
European Journal of Pharmaceutics and Biopharmaceutics
@nb
European Journal of Pharmaceutics and Biopharmaceutics
@nl
P31
P243
P3181
P1055
P1058
P1156
P1160
Eur. J. Pharm. Biopharm.
P123
P1250
P1277
P1476
European Journal of Pharmaceutics and Biopharmaceutics
@en
P236
P243
P3181
P407
P495
P571
1997-01-01T00:00:00Z